MRNAHealthcare · Biotechnology
MRNA
DeepValues Research covers MRNA with 1 research report since Sep 27, 2026. The latest Deep Value Intelligence report (Sep 27, 2026) ends with a Neutral stance (3.01/5), with the stock at $199 against a headline intrinsic value of $448. Sector: Healthcare · Biotechnology.
Research timeline
-
Deep Value Intelligence
MRNA Deep Value Intelligence ReportNeutral (3.01/5) on MRNA, Sep 27, 2026. Price $199 vs intrinsic value $448, 55.6% margin of safety. Moderna is a scientifically important biotechnology…
Compare with other Healthcare companies
All Healthcare stocks| Company | Latest stance | Reports |
|---|---|---|
| MRNA | Neutral3.01 | 1 |
| ALLOAllogene Therapeutics | Bearish3.10 | 1 |
| CRSPCRISPR Therapeutics | Neutral2.30 | 1 |
| INSMInsmed | Bearish2.52 | 1 |
| GMABGenmab A/S | Bearish4.01 | 1 |
| MNKDMannKind | Neutral2.63 | 1 |
| TPSTTempest Therapeutics | Bearish2.65 | 1 |
| ADMAADMA Biologics | Neutral3.37 | 1 |
| LENZLENZ Therapeutics | Bearish3.12 | 1 |
Charts from the latest report
Open report
